Leonteq Securities’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.3K Sell
500
-500
-50% -$11.2K ﹤0.01% 967
2026
Q2
$17.8K Buy
+1,000
New +$17.9K ﹤0.01% 970

Other funds holding CAI

Leonteq Securities's CAI Position: Q3 2026 in Review

Leonteq Securities reduced its Caris Life Sciences (CAI) stake by 50% in Q3 2026, selling an estimated $11.2K and leaving 500 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Leonteq Securities first reported a position in CAI in Q2 2026 and has held it in 2 quarters since. The position peaked at $17.8K in Q2 2026. 255 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Leonteq Securities held 500 shares of Caris Life Sciences worth $15.3K as of Q3 2026.
  • Leonteq Securities sold 500 Caris Life Sciences shares in Q3 2026, an estimated $11.2K.
  • Caris Life Sciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #967 holding.
  • Leonteq Securities first reported a position in Caris Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Leonteq Securities's Caris Life Sciences position peaked at $17.8K in Q2 2026.
  • 255 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.